Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
737,449
-
Total 13F shares
-
942,533
-
Share change
-
+485,181
-
Total reported value
-
$2,982,000
-
Price per share
-
$3.15
-
Number of holders
-
10
-
Value change
-
+$1,514,077
-
Number of buys
-
3
-
Number of sells
-
6
Institutional Holders of InMed Pharmaceuticals Inc. - Common Stock (INM) as of Q2 2021
As of 30 Jun 2021 InMed Pharmaceuticals Inc. - Common Stock (INM) had 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 942,533 shares of stock of the company.
Largest 10 holders included ARMISTICE CAPITAL, LLC, Penserra Capital Management LLC, CITADEL ADVISORS LLC, Creative Planning, UBS Group AG, PNC Financial Services Group, Inc., MORGAN STANLEY, REILLY FINANCIAL ADVISORS, LLC, AllSquare Wealth Management LLC, and Federation des caisses Desjardins du Quebec.
This table shows 11 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.